MDM2 SNP309 polymorphism contributes to endometrial cancer susceptibility: evidence from a meta-analysis

OBJECTIVE: The SNP309 polymorphism (T-G) in the promoter of MDM2 gene has been reported to be associated with enhanced MDM2 expression and tumor development. Studies investigating the association between MDM2 SNP309 polymorphism and endometrial cancer risk reported conflicting results. We performed...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Qiliu, Mo, Cuiju, Qin, Aiping, Lao, Xianjun, Chen, Zhiping, Sui, Jingzhe, Wu, Junrong, Zhai, Limin, Yang, Shi, Qin, Xue, Li, Shan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029393/
https://www.ncbi.nlm.nih.gov/pubmed/24423195
http://dx.doi.org/10.1186/1756-9966-32-85

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029393/
https://www.ncbi.nlm.nih.gov/pubmed/24423195
http://dx.doi.org/10.1186/1756-9966-32-85

Ejemplares similares